Jord BioScience

Jord BioScience

Private
MinnesotaFrontier & Industrial Techhttps://jordbioscience.com

Last Round

Series B

Feb 19, 2025

Total Funding Raised

$7M

Momentum Score

25 /100

Company Overview

Jord BioScience is a US-based biotechnology company that develops customizable microbial solutions for the agricultural industry. Founded on over 30 years of research from the University of Minnesota, the company leverages a proprietary microbial bank of over 6,500 isolates to create products that enhance crop health and productivity. Jord BioScience partners with agribusinesses to accelerate the development and commercialization of next-generation biological crop inputs, such as inoculants and seed treatments, aiming to improve yield consistency and promote sustainable farming practices. The company's technology is designed to work with existing commercial products to boost their performance and extend their lifecycle.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

microbial solutionsagricultural biologicalscustom microbial inoculantsagtechag biotechmicrobial R&Dmicrobial bankbiostimulantsbiofungicidesbiology-as-a-servicemicrobiome analysissustainable agriculturebiofertilizerscrop performancecrop protection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jord BioScience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Jord BioScience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 19, 2025

Key People

Founding team and executive leadership

Keri Carstens

Chief Executive Officer

Executive Team

Jord BioScience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2025

    Rob DeWolfe appointed Chief Financial and Operating Officer.

  • Feb 19, 2025

    $7M round completed.

Jord BioScience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jord BioScience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jord BioScience's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinnesota
Employee Range20
Year Founded2019
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.